It has been revealed that an injection of a single-dose Fas siRNA through the renal vein post ischemia provided a survival advantage in a murine IR model, which was due to the anti-apoptosis and anti-inflammation effects of the Fas siRNA [28]. Here, FAS is linked to ischemia.